- Home
- AI vs RXRX Comparison
AI vs RXRX Comparison
Compare AI & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AI
- RXRX
- Stock Information
- Founded
- AI 2009
- RXRX 2013
- Country
- AI United States
- RXRX United States
- Employees
- AI N/A
- RXRX N/A
- Industry
- AI Computer Software: Prepackaged Software
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- AI Technology
- RXRX Health Care
- Exchange
- AI Nasdaq
- RXRX Nasdaq
- Market Cap
- AI 2.3B
- RXRX 2.4B
- IPO Year
- AI 2020
- RXRX 2021
- Fundamental
- Price
- AI $15.62
- RXRX $4.61
- Analyst Decision
- AI Hold
- RXRX Buy
- Analyst Count
- AI 15
- RXRX 5
- Target Price
- AI $25.38
- RXRX $7.00
- AVG Volume (30 Days)
- AI 12.8M
- RXRX 15.9M
- Earning Date
- AI 09-03-2025
- RXRX 11-05-2025
- Dividend Yield
- AI N/A
- RXRX N/A
- EPS Growth
- AI N/A
- RXRX N/A
- EPS
- AI N/A
- RXRX N/A
- Revenue
- AI $372,104,000.00
- RXRX $64,596,000.00
- Revenue This Year
- AI $13.06
- RXRX $24.09
- Revenue Next Year
- AI $15.85
- RXRX $20.99
- P/E Ratio
- AI N/A
- RXRX N/A
- Revenue Growth
- AI 14.34
- RXRX 30.14
- 52 Week Low
- AI $14.70
- RXRX $3.79
- 52 Week High
- AI $45.08
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- AI 28.01
- RXRX 36.12
- Support Level
- AI $14.80
- RXRX $4.53
- Resistance Level
- AI $17.54
- RXRX $4.82
- Average True Range (ATR)
- AI 0.71
- RXRX 0.25
- MACD
- AI 0.08
- RXRX -0.04
- Stochastic Oscillator
- AI 22.06
- RXRX 12.45
About AI C3.ai Inc.
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.